PWPS
PTCT icon

Pinnacle Wealth Planning Services’s PTC Therapeutics PTCT Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101K Buy
1,241
+12
+1% +$867 0.01% 861
2026
Q1 		$83.7K Buy
1,229
+675
+122% +$47.8K 0.01% 889
2025
Q4 		$42.1K Buy
+554
New +$40.3K ﹤0.01% 1321
2021
Q1 		– Sell
-218
Closed -$13K – 1555
2020
Q4 		$13K Buy
+218
New +$12.8K ﹤0.01% 1314

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Pinnacle Wealth Planning Services's PTCT Position: Q2 2026 in Review

Pinnacle Wealth Planning Services increased its PTC Therapeutics (PTCT) stake by 0.98% in Q2 2026, buying an estimated $867 and bringing the position to 1,241 shares worth $101K. The position accounts for 0.01% of the portfolio, ranked #861.

Pinnacle Wealth Planning Services first reported a position in PTCT in Q4 2020 and has held it in 4 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Pinnacle Wealth Planning Services held 1,241 shares of PTC Therapeutics worth $101K as of Q2 2026.
  • Pinnacle Wealth Planning Services bought 12 PTC Therapeutics shares in Q2 2026, an estimated $867.
  • PTC Therapeutics made up 0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #861 holding.
  • Pinnacle Wealth Planning Services first reported a position in PTC Therapeutics in Q4 2020 and has held it in 4 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.